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no rupture of aneurysmal wall and no migration, leakage or damage (rupture
of Dacron cylinder or fracture of wire frame) of graft in all dogs. These grafts
remained patent and pressure gradient (PG) was 14 mmHg except one (PG =
60 mmHgl. This was killed and examined by autopsy. The graft was well cov-
ered by thin, translucent neointima and effectively recreated the new aortic
lumen, completely closing the entry.
Conclusion: 1) Inoue Endovascular Graft was proved to be effective in
treatment of aortic dissection without surgery provided that the graft was
chosen according to true lumen diameter. 2) IVUS was feasible and safe to
provide accurate measurement of true lumen diameter for selection of cor·
rect graft size and guide for implantation site to completely close the entry
lumen.
A feasibility study was conducted for the transcatheter occlusion of large
ostium secundum atrial septal defects (ASOs) using the centering buttoned
device (CBO). The CBO is a modification of the buttoned device, in which a
centering counter-occluder (COC) is sutured at the central 40% portion of the
occluder (OCC); when the centering COC is stretched is forming a balloon
shaped structure, pulling the OCC over the center of the ASO; subsequently
the COC is buttoned with the OCC, forming a double 8 disk on the right side
of the atrial septum. Occlusion was performed in 10 patients 6-56 years old
(median 22). All had been rejected for occlusion by the regular buttoned de-
vice, either because of large defect size, or inadequate septal rim. The defect
size varied between 23-31 mm (median 27) and the device size between 45-
60 mm (median 50). All devices were introduced through 11 F long sheaths.
All patients remained stable. Seven had immediate effective occlusions and
three had residual shunts. Follow·up ranged between 2-6 months. Unbut-
toning without embolization was experienced in the second case; despite
the trivial residual shunt, the patient developed severe hemolysis and was
operated 2 weeks after implantation. The other patients are doing well.
Conclusions: The CBO can offer transcatheter repair in large ASDs cor-
rected only by Surgery in the past. The early results are promising; larger
trials are justified.
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Thrombus formation at sites of vascular injury provides cytokines, growth
factors, and biodegradable matrix for cellular migration, proliferation, and
matrix synthesis. We hypothesized that potent limitation ofthrombus deposi-
tion following coronary arterial injury would significantly attenuate restenotic
neointimal formation. Following oversized metallic coil implantation, 26 do-
mestic pigs received either recombinant PEG Hirudin, (7 animals, 1 mg!kg
IV bolus, 0.1 mg!kglhr IV for 5 days) with a goal of keeping the ACT at 200
seconds, or placebo (12 animals). Survival until euthanasia was 28 ± 2 days.
Linear regression models were constructed for planimetered mean neointi-
mal (NI) thickness vs. mean vascular injury score (INJ).
The neointima vs. injury regression equations for each group showed sta-
tistically significant differences in intercept, but not slope:
lumenal patency which appears to be associated with chronic geometric re-
modeling despite concurrent intimal proliferation. Treatment of traumatized
coronary arteries with CB may be useful in diminishing restenosis in patients
undergoing PTCA.
Conclusions: rPEG Hirudin administered early and in doses sufficient to
maintain the activated clotting time at 200 seconds decreased the mean
NI by 0.27 mm, a difference that would be angiographically detectable and
clinically significant.
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The predominant role of geometric remodeling in restenosis after percu-
taneous coronary angioplasty (PTCA) has recently been described. In this
study, Cytochalasin B (CB), a compound which reversibly blocks actin poly-
merization and thereby inhibits smooth muscle contraction and geometric
remodeling, was tested for its abilityto inhibit restenosis after balloon trauma
in a swine coronary model. The left circumflex artery was traumatized with a
torquable embolectomy catheter and treated with either saline, 0.1 "g/ml or
1.5 flg/ml CB applied directly to the arterial wall with a Cordis Microporous
Infusion Catheter (MIC). Pigs were sacrificed 3 weeks post-surgery and the
left coronary artery was processed for histopathology. Histologically, trauma-
tized and treated coronary arteries in all groups were characterized by tears
in the internal elastic lamina which occasionally extended into the tunica me-
dia, reorientation of the inner myofibers of the tunica media perpendicular to
the lumen, occasional dissecting aneurysms, and intimal hyperplasia. Mor-
phometric evaluation of vascular lumenal area demonstrated a significant
difference between treatment groups and the saline control. Saline control
pigs had a mean lumenal area of 55.8% (44.2% stenosis) compared to the
mean of the proximal and distal vessel lumen areas. Pigs treated with 0.1
flg/ml CB had lumenal areas of 92.1 % (7.9% stenosis, p < 0.01). and pigs
treated with 1.5 flg/ml CB had lumenal areas of 112.4% (12.4% dilation, p
= 0.001). Treatment with 0.1 flg/ml CB markedly inhibited restenosis and
treatment with 1.5 flg/ml CB actually resulted in increased in lumenal area.
In this model of vascular injury, treatment with CB resulted in increased
Conclusions: Prolonged low dose local infusion of AP at the injury site
reduced the neointima and improved the residual lumen in the treated ves-
sel. The beneficial effect of AP was not demonstrated with the higher dose,
shorter duration local infusion.
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Local infusion of angiopeptin lAP) into injured swine coronary arteries using
the porous balloon has been shown to reduce neointima. The purpose of this
study was to compare prolonged (20 min) infusion of low dose AP (20 "g!kg)
with a short (3 mini infusion of high dose AP (500 "g!kg) using the Dispatch ,.
device which allows atraumatic and extended drug/arterial wall contact. 21
swine underwent overstretch balloon injury to the coronary arteries. AP was
infused at either low or high dose immediately post-injury. Vessels were har-
vested at 14 days and the neointimal area (NEG). % neointima INEOIWall
Area), % internal elastic lamina fracture (IEL break/lEL length) and residual
lumen (lumen area~umen area + intimal area) were determined.
P. Gonschior, C. Pahl, B. Holling. Med. Dept. I, Klinikum Grof3hadern, University of
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Tissue hyperplasia is a characteristic feature of restenotic tissue. Local appli-
cation of antiproliferative drugs e.g. Photofrin II® (PFII; OLT, Canada). a pho-
tosensitive drug, might enable selective impairment of proliferating tissue
by photodynamic therapy or other antiproliferative strategies. The efficacy
of this therapy depends mainly on the method of drug application. Local
drug delivery (LDD) consisting of six thin injection needles (31 G) that can
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